Bradley Stuart DeHoff

Title: The Innovations of Bradley Stuart DeHoff

Introduction

Bradley Stuart DeHoff is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid compounds and polyketide synthase genes. With a total of two patents to his name, DeHoff's work has implications for various applications in medicine and agriculture.

Latest Patents

DeHoff's latest patents include the invention of a novel SAM synthetase. This invention provides isolated nucleic acid compounds that encode the SAM synthetase, along with vectors and transformed heterologous host cells for expressing this enzyme. Additionally, he has developed a method for preparing S-adenosylmethionine from recombinant host cells transformed with the SAM synthetase gene. Another significant patent involves a DNA molecule isolated from Streptomyces fradiae, which encodes multi-functional proteins that direct the synthesis of the polyketide tylactone.

Career Highlights

Bradley Stuart DeHoff is currently associated with Eli Lilly and Company, where he continues to innovate and contribute to the field of biotechnology. His work has been instrumental in advancing the understanding and application of genetic engineering techniques.

Collaborations

Throughout his career, DeHoff has collaborated with esteemed colleagues such as Stuart A Kuhstoss and Paul R Rosteck, Jr. These collaborations have further enriched his research and development efforts.

Conclusion

Bradley Stuart DeHoff's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in genetic engineering and its applications.